Multicenter, double-blind randomized, controlled study for the treatment of involutional osteoporosis
Phase 3
- Conditions
- Involutional osteoporosis
- Registration Number
- JPRN-jRCT2080220084
- Lead Sponsor
- ONO PHARMACEUTICAL CO.,LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- Female
- Target Recruitment
- Not specified
Inclusion Criteria
Patients of female aged 55 years or older and under 81 years with documented involutional osteoporosis with prevalent fracture according to the diagnostic criteria for primaly osteoporosis
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method